From December 26 to 27, 2025, Distinguished Professor Chen Xin, Director of both the Institute of Chinese Medical Sciences (ICMS) and the State Key Laboratory of Mechanism and Quality of Chinese Medicine, led a delegation to Guangzhou, upon the invitation of Guangzhou Pharmaceutical Holdings, to attend the “2025 Guangzhou Pharmaceutical Holdings Innovation Conference.” The ICMS delegation included Professor Wan Jianbo, Associate Director of ICMS; Associate Professor Wang Shengpeng, Assistant Director of the State Key Laboratory; as well as Assistant Professors Cao Junjie and Li Chihua.
During the conference, Professor Chen met with Mr. Li Xiaojun, Chairman of Guangzhou Pharmaceutical Holdings, and senior executives from its affiliated enterprises for in-depth discussions. Professor Chen provided a comprehensive overview of the progress and future development plans of the State Key Laboratory of Mechanism and Quality of Chinese Medicine. In turn, Chairman Li outlined Guangzhou Pharmaceutical Holdings’ strategic direction to accelerate its transformation into a technology-driven and innovation-oriented enterprise group.
Both parties expressed strong consensus on further deepening collaboration, leveraging their respective strengths in traditional Chinese medicine (TCM) industrial resources and scientific innovation to jointly advance innovative TCM research and development, expedite the internationalization of TCM, and co-create a high-quality development framework for Guangdong-Macao cooperation in the TCM sector.
Additionally, during the event, Guangzhou Pharmaceutical Holdings conferred the titles of “Chief Expert Advisor” and “Senior Expert Advisor” upon Professor Chen Xin and Associate Professor Wang Shengpeng, respectively.
Professor Chen Xin, ICMS director met with Mr. Li Xiaojun, Chairman of Guangzhou Pharmaceutical Holdings
Discussion